Attention Deficit Hyperactivity Disorder
📧 Sign up to get email alerts when something new happens for Attention Deficit Hyperactivity Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-03-05Clinical Trial Update: Does Active Parent Involvement in Deliberation and Choice Improve Medication Persistence for Their Child With ADHD [NA]
This update describes a completed ADHD clinical trial evaluating whether active parent involvement in deliberation and decision-making impro…
-
CLINICAL_TRIALS trial_result · 2015-03-04Clinical Trial Update: Safety and Tolerability Study of Metadoxine Extended Release (MDX) (Previously Known as MG01CI) in PI-ADHD Adolescent Subjects [Phase 2]
Phase 2 safety and tolerability study of metadoxine extended release (MDX) in adolescents with ADHD (predominantly inattentive type) has com…
-
FDA approval · 2015-03-03FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application from Prasco Laboratories for a generic product containing four amphetamine salts (dextroamphetamine …
-
FDA approval · 2015-03-02FDA Approved: DEXTROAMPHETAMINE SULFATE EXTENDED-RELEASE — Supplemental Application (SpecGx LLC)
The FDA granted approval of a supplemental application for dextroamphetamine sulfate extended-release from SpecGx LLC, updating the regulato…
-
FDA approval · 2015-02-25FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Original Application (Lupin Pharmaceuticals,Inc.)
The FDA approved Lupin Pharmaceuticals' methylphenidate hydrochloride generic through an Original Application (ANDA 204115).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-02-09Clinical Trial Update: Study of the Effect of Calorie Supplementation on Growth in Young Children on ADHD Medication [NA]
A completed clinical trial evaluating the effect of calorie supplementation on growth in young children on ADHD medication; results posted i…
-
FDA approval · 2015-02-04FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for a generic product containing four amphetamine salt components. The approval supports use for att…
-
FDA approval · 2015-02-04FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (Epic Pharma, LLC)
FDA approved a supplemental application for a generic combination of amphetamine salts (dextroamphetamine saccharate, amphetamine aspartate,…
-
CLINICAL_TRIALS research · 2015-02-02Clinical Trial Update: Study of an Intervention to Improve Problem List Accuracy and Use [NA]
Clinical trial update from Brigham and Women's Hospital about a study to improve the accuracy and use of patients' problem lists across mult…
-
FDA approval · 2015-01-30FDA Approved: VYVANSE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Vyvanse (lisdexamfetamine dimesylate) submitted by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2015-01-29FDA Approved: DEXTROAMPHETAMINE SULFATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for dextroamphetamine sulfate by Teva Pharmaceuticals USA, Inc. This action represents an approv…
-
FDA approval · 2015-01-29FDA Approved: DEXTROAMPHETAMINE SULFATE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for dextroamphetamine sulfate from SpecGx LLC under an Abbreviated New Drug Application.
-
FDA approval · 2015-01-29FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application from Sandoz Inc for a generic mixed amphetamine salt product containing dextroamphetamine and amphet…
-
FDA approval · 2015-01-29FDA Approved: DEXTROAMPHETAMINE SACCHARATE AND AMPHETAMINE ASPARTATE AND DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental ANDA for a generic fixed-dose combination of dextroamphetamine and amphetamine salts (dextroamphetamine sacchara…
-
CLINICAL_TRIALS trial_result · 2015-01-21Clinical Trial Update: A Study on the Inter-Hemispheric Alpha Ratio in Kids With ADHD (SHARK)
This clinical trial update reports the completion of a study examining the inter-hemispheric alpha ratio in children with ADHD (SHARK). The …
-
CLINICAL_TRIALS trial_result · 2015-01-16Clinical Trial Update: Methylphenidate Transdermal System (MTS) in the Treatment of Adult ADHD [Phase 3]
Phase 3 trial evaluating the methylphenidate transdermal system for adults with ADHD has completed and posted results.
-
FDA approval · 2015-01-15FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical's supplemental application for a generic product containing the four amphetamine salt components (mixed amph…
-
CLINICAL_TRIALS trial_result · 2015-01-12Clinical Trial Update: Adult Attention Deficit Hyperactivity Disorder [Phase 2]
Phase 2 clinical trial update for adults with attention-deficit/hyperactivity disorder has completed with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-01-07Clinical Trial Update: NIRS Neurofeedback as a Treatment for Attention Deficit Hyperactivity Disorder [Phase 2]
Phase 2 clinical trial evaluating near-infrared spectroscopy (NIRS) neurofeedback as a treatment for Attention Deficit Hyperactivity Disorde…
-
CLINICAL_TRIALS trial_result · 2014-12-31Clinical Trial Update: Behavioral Intervention for Children With Attention Deficit Hyperactivity Disorder(ADHD) [Phase 1]
An early-phase Phase 1 clinical trial evaluating a behavioral intervention for children with Attention Deficit Hyperactivity Disorder.
-
CLINICAL_TRIALS research · 2014-12-31Clinical Trial Update: Prevalence of Attention Deficit Disorder Among Patients With Constitutional Growth Delay
This entry reports on a clinical trial investigating how common attention-deficit/hyperactivity disorder is in people with constitutional gr…
-
CLINICAL_TRIALS research · 2014-12-23Clinical Trial Update: Phase IIa Exploratory Clinical Trial, to Examine the Safety and Efficacy of tPCS on Paediatric ADHD Participants [Phase 2]
Phase IIa exploratory trial evaluating safety and efficacy of transcranial pulsed current stimulation (tPCS) in pediatric ADHD; current tria…
-
CLINICAL_TRIALS research · 2014-12-17Clinical Trial Update: Psychostimulants Effects on Brain Functional Connectivity in Youth With Attention Deficit Hyperactivity Disorder [NA]
Clinical trial update examining the effects of psychostimulants on brain functional connectivity in youths with attention-deficit/hyperactiv…
-
CLINICAL_TRIALS trial_result · 2014-12-17Clinical Trial Update: Preventing Health Disparities in Hispanic Youth [NA]
A completed clinical trial conducted by the University of Miami aimed at preventing health disparities in Hispanic youth, with conditions in…
-
CLINICAL_TRIALS trial_result · 2014-12-15Clinical Trial Update: Study of Aripiprazole (Abilify) in Children With ADHD (Attention Deficit Hyperactivity Disorder) [Phase 4]
Phase 4 clinical trial update for aripiprazole (Abilify) in children with Attention-Deficit/Hyperactivity Disorder; the study has completed.